Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences
Dec 05, 2016 12:00 pm UTC| Business
Exclusive use of Selecta’s Synthetic Vaccine Particles (SVP™) platform technology provided to Spark Therapeutics for co-administration with up to five gene therapy targets, including FVIII for hemophilia A ...
Dec 05, 2016 12:00 pm UTC| Business
-Phase Ib cohorts demonstrate dose effect and additional support for once daily dosing--PAS-Coversin pre-clinical data supports once weekly dosing--Phase II PNH patients identified with data expected 1Q17--Eculizumab...
Dec 05, 2016 12:00 pm UTC| Business
- Posters Presented at American Epilepsy Society Annual Meeting -- New data includes key secondary efficacy endpoints - LONDON, Dec. 05, 2016 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a...
M2 Compliance™ to Sponsor the 9th Annual LD Micro Main Event
Dec 05, 2016 12:00 pm UTC| Business
LOS ANGELES, Dec. 05, 2016 -- M2 Compliance Incorporated, an industry-leading SEC Filing Agent and Financial Printer, is proud to announce its participation as the co-main sponsor of the 9th Annual LD Micro Main Event...
Dec 05, 2016 12:00 pm UTC| Business
Program On Track to Begin Dosing in Phase 1B/2 Study of Patients with B-Cell Malignancies in the First Half of 2017 SOUTH SAN FRANCISCO, Calif., Dec. 05, 2016 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today...
AGTC to Present at Upcoming Conferences
Dec 05, 2016 12:00 pm UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Dec. 05, 2016 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Consolidated Communications to Acquire FairPoint Communications, Inc.
Dec 05, 2016 12:00 pm UTC| Business
Creates a stronger business and broadband communications provider to better serve its customersDoubles revenue, adjusted EBITDA and provides significant scale and resourcesIncreases fiber route miles to 35,100 across 24...